Acumen Pharmaceuticals (ABOS)
US Market

Acumen Pharmaceuticals (ABOS) Financial Statements


Acumen Pharmaceuticals Financial Overview

Acumen Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.105; its P/E ratio is -4.47; Acumen Pharmaceuticals is scheduled to report earnings on November 13, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue-$ -1.00K$ 0.00$ 0.00$ 0.00
Gross Profit-$ -1.00K---
EBIT$ -13.14M$ -14.26M$ -11.37M$ -10.41M$ -9.21M
EBITDA$ -13.42M$ -14.30M$ -11.33M$ -10.37M$ -9.17M
Net Income Common Stockholders$ -11.31M$ -12.87M$ -10.71M$ -10.15M$ -9.13M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 140.41M$ 177.60M$ 200.19M$ 189.91M$ 189.09M
Total Assets$ 187.71M$ 196.59M$ 203.26M$ 211.68M$ 220.09M
Total Debt$ 67.00K$ 105.00K$ 133.00K$ 167.00K$ 201.00K
Net Debt$ -140.34M$ -177.50M$ -200.06M$ -189.74M$ -188.89M
Total Liabilities$ 8.26M$ 7.81M$ 6.61M$ 5.16M$ 4.00M
Stockholders Equity$ 179.64M$ 188.78M$ 196.65M$ 206.52M$ 216.09M
Cash Flow-
Free Cash Flow$ -10.18M$ -11.24M$ -9.26M$ -6.50M$ -8.31M
Operating Cash Flow$ -10.18M$ -11.20M$ -9.18M$ -6.47M$ -8.30M
Investing Cash Flow$ -41.93M$ -20.42M$ 55.92M$ 8.79M$ -5.10M
Financing Cash Flow-$ 4.18M$ -263.00K--
Currency in USD

Acumen Pharmaceuticals Earnings and Revenue History

Acumen Pharmaceuticals Debt to Assets

Acumen Pharmaceuticals Cash Flow

Acumen Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis